Genfit S.A. (GNFTF)
OTCMKTS
· Delayed Price · Currency is USD
3.540
+0.100 (2.91%)
At close: Dec 27, 2024
Genfit Employees
Genfit had 180 employees as of December 31, 2024. The number of employees increased by 21 or 13.21% compared to the previous year.
Employees
180
Change (1Y)
21
Growth (1Y)
13.21%
Revenue / Employee
$406,598
Profits / Employee
$8,668
Market Cap
217.27M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Tian'an Technology Group | 8 |
Glass House Brands | 374 |
CytoDyn | 9 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Genfit News
- 21 days ago - Genfit S.A. reports Q1 results - Seeking Alpha
- 21 days ago - GENFIT Reports First Quarter 2025 Financial Information - GlobeNewsWire
- 23 days ago - GENFIT to receive a €26.5 million milestone payment following the approval of pricing and reimbursement of Ipsen's Iqirvo® in Italy - GlobeNewsWire
- 4 weeks ago - GENFIT: Publication of the 2025 Extra-Financial Performance Report (fiscal year 2024) - GlobeNewsWire
- 5 weeks ago - GENFIT Annual Combined General Meeting of June 17, 2025 — Availability of Preparatory Documents - GlobeNewsWire
- 5 weeks ago - GENFIT to Present Latest ACLF Research at EASL Congress 2025 - GlobeNewsWire
- 6 weeks ago - GENFIT Announces Publication of the 2024 Universal Registration Document and the 2024 Annual Report on Form 20-F - GlobeNewsWire
- 6 weeks ago - GENFIT: positive late-breaking Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented by Ipsen at EASL Congress 2025 - GlobeNewsWire